Integra LifeSciences (IART) Tops Q1 EPS by 12c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Integra LifeSciences (IART) PT Raised to $78 at BTIG
April 28, 2021 1:16 PM EDTBTIG analyst Ryan Zimmerman raised the price target on Integra LifeSciences (NASDAQ: IART) to $78.00 (from $74.00) while maintaining a Buy rating.
The analyst commented, "We maintain our Buy and raise our IART PT to $78 (from $74) following better-than-expected 1Q21 results. Rev. of $360.1M (1.6% Y/Y,... More
